Financial reports
10-Q
2022 Q1
Quarterly report
16 May 22
10-K
2021 FY
Annual report
30 Mar 22
10-K/A
2020 FY
Annual report (amended)
13 Dec 21
10-Q
2021 Q3
Quarterly report
15 Nov 21
10-Q
2021 Q2
Quarterly report
16 Aug 21
10-Q
2021 Q1
Quarterly report
19 May 21
10-K/A
2020 FY
Annual report (amended)
19 May 21
NT 10-Q
Notice of late quarterly filing
18 May 21
10-K
2020 FY
Annual report
31 Mar 21
Current reports
8-K
Alvotech and Oaktree Acquisition Corp. II Announce Shareholder Approval of Business Combination
7 Jun 22
8-K
Business Combination remains subject to satisfaction of customary closing conditions, including approval of Oaktree’s shareholders
3 Jun 22
8-K
Other Events
31 May 22
8-K
Regulation FD Disclosure
17 May 22
8-K
Entry into a Material Definitive Agreement
22 Apr 22
8-K
Departure of Directors or Certain Officers
18 Apr 22
8-K
Upon launch, HUKYNDRA® will be one of two citrate-free, high-concentration adalimumab biosimilars on the European market
6 Apr 22
8-K
Regulation FD Disclosure
23 Mar 22
8-K
Regulation FD Disclosure
8 Mar 22
8-K
Entry into a Material Definitive Agreement
18 Jan 22
Registration and prospectus
25
Voluntary exchange delisting
15 Jun 22
425
Business combination disclosure
9 Jun 22
425
Business combination disclosure
7 Jun 22
425
Business combination disclosure
3 Jun 22
425
Business combination disclosure
31 May 22
425
Business combination disclosure
24 May 22
425
Business combination disclosure
17 May 22
425
Business combination disclosure
16 May 22
425
Business combination disclosure
11 May 22
425
Business combination disclosure
22 Apr 22
Ownership
SC 13G
MILLENNIUM MANAGEMENT LLC
16 Feb 22
SC 13G/A
INTEGRATED CORE STRATEGIES (US) LLC
7 Feb 22
3/A
Initial statement of insider ownership (amended)
16 Feb 21
SC 13G
Oaktree Acquisition Holdings II, L.P.
16 Feb 21
SC 13G/A
INTEGRATED CORE STRATEGIES (US) LLC
26 Jan 21
SC 13G
INTEGRATED CORE STRATEGIES (US) LLC
22 Sep 20
4
Change in insider ownership
22 Sep 20
3
Andrea L Wong
16 Sep 20
3
Patrick McCaney
16 Sep 20
3
ANTHONY GRILLO
16 Sep 20